Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


09 mayo 2013

Glue a promising tool in the varicose vein occlusion armamentarium

Vascular News

Gerard Stansby, Newcastle, UK, told delegates at CX35 (6–9 April 2013, London, UK) that the use of glue in varicose veins in safe and effective and that, if it continues to show good results, it will be a very attractive procedure for the future.

07 mayo 2013

Radiosurgery treatments for lung cancer using Varian Medical Systems Technologies presented at ESTRO

Interventional News

Detailed experiences of stereotactic ablative body radiotherapy (SABR) treatments using Varian’s TrueBeam medical linear accelerator and Calypso “GPS for the Body” tumour-tracking technology were discussed at the annual European Society for Radiotherapy and Oncology (ESTRO) Forum (19–23 April 2013, Geneva, Switzerland) at the Varian Emerging Technologies Symposium.

18 abril 2013

Examen de antígeno prostático eleva número de procedimientos y riesgos: estudio

Reuters Health

La mayoría de los adultos mayores en Estados Unidos a los que se les diagnosticó un cáncer con el antígeno prostático específico (PSA, por su nombre en inglés) decidió someterse a un tratamiento, aún cuando los signos revelaban una enfermedad de avance muy lento, indicó un reciente estudio.

03 mayo 2013

Cost effective prostate cancer treatment underused in the UK

Interventional News

The study, which was presented at the European Society for Radiotherapy and Oncology (ESTRO) 19 to 23 April 2013, Geneva, Switzerland, used the latest cost effectiveness model to look at relevant recent data for prostate cancer. The study analysed research findings from six recent overview studies, involving 55,000 patients and looked at disease progression, associated costs and outcomes extrapolated over a ten-year time horizon from a UK National Health Service (NHS) cost perspective.

02 mayo 2013

Cook Medical announces CE mark approval for PVA foam embolization particles

Interventional News

Cook Medical, on the 1 May 2013, announced it had received CE mark approval for their PVA foam embolization particles to treat benign prostatic hyperplasia. According to a company release, the PVA foam embolization particles will be shown at the Global Embolization Symposium and Technologies (GEST) 1–4 May 2013 in Prague, Czech Republic.

26 abril 2013

Stenting dramatically improves treatment access for dialysis patients

Interventional News

The RENOVA (Post-approval study for the Flair endovascular stent graft) results showed that stent grafts keep access sites open significantly longer in haemodialysis patients than angioplasty alone, according to a presentation given at the Society of Interventional Radiology’s (SIR) Annual Meeting (13−18 April 2013, New Orleans, USA).

18 abril 2013

Significant palliation of spinal tumours with ablation system

Interventional News

Dfine has announced that two studies presented at the Society of Interventional Radiology s (SIR) annual scientific meeting (13–18 April, New Orleans, USA) have underscored the benefits of targeted-radiofrequency ablation therapy (t-RFA) using Dfine’s Star tumour ablation system for the treatment of painful malignant lesions of the vertebral body.

14 abril 2013

Study at SIR Shows Safety and Effectiveness of Stenting CTOs of Mesenteric Arteries

Endovascular Today

April 14, 2013—The Society of Interventional Radiology (SIR) announced the presentation of a study at SIR’s 38th Annual Scientific Meeting in New Orleans, Louisiana, demonstrating that stenting reopens completely blocked bowel arteries. Chronic mesenteric ischemia can cause dangerous weight loss, malnourishment, and death because the intestines are prevented from receiving the oxygen-rich blood they require to digest food, noted SIR.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.